down arrow

ERIS Lifescience

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,361.10
21.1 (1.57%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.29 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,188.34
1,458.22
1,282.35
1,041.09
933.66
825.50
763.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
3.62
Total Operating income
2,188.34
1,458.22
1,282.35
1,041.09
933.66
825.50
767.35
Raw Material Cost
208.06
126.64
109.66
87.56
77.34
52.87
46.64
Purchase of Finished goods
377.14
143.00
151.84
100.37
135.97
56.41
75.01
(Increase) / Decrease In Stocks
-41.46
-7.78
18.11
8.77
-35.47
25.16
-2.83
Employee Cost
383.64
301.35
260.35
188.79
176.79
150.09
143.43
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.02
0.01
0.00
-0.01
150.30
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
496.15
368.61
324.55
267.55
242.98
249.84
72.03
Total Expenditure (Excl Depreciation)
1,423.53
931.82
864.49
653.05
597.61
534.36
484.58
Operating Profit (PBDIT) excl Other Income
764.81
526.40
417.86
388.04
336.05
291.14
282.77
Other Income
10.41
8.67
10.15
18.03
6.49
16.47
19.97
Operating Profit (PBDIT)
775.22
535.07
428.01
406.07
342.54
307.61
302.74
Interest
177.01
51.77
17.30
2.89
1.26
1.81
18.46
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
598.21
483.30
410.71
403.18
341.28
305.80
284.27
Depreciation
237.62
128.71
81.96
46.34
31.52
35.94
25.15
Profit Before Tax
360.59
354.59
328.74
356.86
309.77
269.85
259.12
Tax
87.89
37.17
16.06
31.04
22.89
29.62
21.85
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
272.70
317.42
312.68
325.82
286.89
240.24
237.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
272.70
317.42
312.68
325.82
286.89
240.24
237.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-7.70
1.04
0.80
0.00
0.00
-0.01
-0.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
258.40
321.03
316.74
325.82
286.89
240.23
236.71
Equity Capital
13.61
13.60
13.60
13.59
13.58
13.75
13.75
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
6.14
7.54
7.49
7.41
6.63
4.61
5.83
Operating Profit Margin (Excl OI)
34.95%
36.1%
32.59%
37.27%
35.99%
35.27%
36.85%
Gross Profit Margin
27.34%
33.14%
32.03%
38.73%
36.55%
37.04%
37.05%
PAT Margin
12.46%
21.77%
24.38%
31.3%
30.73%
29.1%
30.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 50.07% vs 13.71% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is -19.51% vs 1.35% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 45.29% vs 25.98% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 241.92% vs 199.25% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of ERIS Lifescience With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,188.34
9,199.93
-7,011.59
-76.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,188.34
9,199.93
-7,011.59
-76.21%
Raw Material Cost
208.06
1,471.08
-1,263.02
-85.86%
Purchase of Finished goods
377.14
1,244.57
-867.43
-69.70%
(Increase) / Decrease In Stocks
-41.46
-93.01
51.55
55.42%
Employee Cost
383.64
1,989.92
-1,606.28
-80.72%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
496.15
2,225.77
-1,729.62
-77.71%
Total Expenditure (Excl Depreciation)
1,423.53
6,838.33
-5,414.80
-79.18%
Operating Profit (PBDIT) excl Other Income
764.81
2,361.60
-1,596.79
-67.61%
Other Income
10.41
287.35
-276.94
-96.38%
Operating Profit (PBDIT)
775.22
2,648.95
-1,873.73
-70.73%
Interest
177.01
238.94
-61.93
-25.92%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
598.21
2,410.01
-1,811.80
-75.18%
Depreciation
237.62
405.66
-168.04
-41.42%
Profit Before Tax
360.59
2,007.79
-1,647.20
-82.04%
Tax
87.89
427.80
-339.91
-79.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
272.70
1,576.55
-1,303.85
-82.70%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
272.70
1,576.55
-1,303.85
-82.70%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
-7.70
-7.70
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
258.40
1,570.19
-1,311.79
-83.54%
Equity Capital
13.61
40.06
-26.45
-66.03%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
27.34%
26.20%
0.00
1.14%
PAT Margin
12.46%
17.14%
0.00
-4.68%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 2,188.34 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 50.07% vs 13.71% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 258.40 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -19.51% vs 1.35% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 764.81 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 45.29% vs 25.98% in Dec 2023

Nine Monthly - Interest
Interest 177.01 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 241.92% vs 199.25% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.95%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023